ARCpoint (TSXV:ARC) Debt-to-Revenue : 1.07 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ARCpoint Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

ARCpoint's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$6.12 Mil. ARCpoint's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$4.33 Mil. ARCpoint's annualized Revenue for the quarter that ended in Dec. 2023 was C$9.82 Mil. ARCpoint's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 1.06.

ARCpoint Debt-to-Revenue Historical Data

The historical data trend for ARCpoint's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARCpoint Debt-to-Revenue Chart

ARCpoint Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

N/A

0.08

0.38

0.74

1.17

ARCpoint Quarterly Data
	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial							1.54	1.17	1.34	1.23	1.07

Competitive Comparison of ARCpoint's Debt-to-Revenue

For the Diagnostics & Research subindustry, ARCpoint's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ARCpoint's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ARCpoint's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where ARCpoint's Debt-to-Revenue falls into.

ARCpoint Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

ARCpoint's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(6.123	+	4.329)	/	8.947
	=	1.17

ARCpoint's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(6.123	+	4.329)	/	9.816
	=	1.06

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.

ARCpoint Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of ARCpoint's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ARCpoint (TSXV:ARC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ARCpoint Inc (TSXV:ARC) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

101 North Main Street, Suite 301, Greenville, SC, USA, 29601

Website

https://www.arcpointlabs.com

ARCpoint Inc is a US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing, and physician services for ARCpoint franchise labs and other clients.